Engflag

Peridone

Quick links to important sections

Peridone

Peridone_EN

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Peridone

What is Peridone?

Peridone is a pharmacological agent primarily classified as a dopamine antagonist. It is utilized in clinical settings to address various gastrointestinal and symptomatic concerns related to motility and nausea.

Mechanism of Action

The active component in Peridone works by selectively blocking dopamine receptors, specifically the D2 receptors. Unlike some other dopamine antagonists, Peridone is designed to act largely in the peripheral nervous system and the area postrema, a region of the brain that lies outside the blood-brain barrier. By inhibiting dopamine's inhibitory effects on the digestive tract, it helps to coordinate and increase the movements of the stomach and intestines.

Therapeutic Use

Peridone is commonly used to manage several specific conditions involving the digestive system:

  • Gastroparesis: It helps facilitate gastric emptying when the stomach muscles do not function efficiently, reducing feelings of early fullness and upper abdominal bloating.
  • Nausea and Vomiting: It is frequently employed to control nausea and vomiting caused by various factors, including the side effects of other medications.
  • Dyspepsia: It may be used to treat chronic indigestion or discomfort in the upper abdomen that is associated with delayed stomach emptying.

By enhancing gastrointestinal transit and preventing the signals that trigger the vomiting reflex, Peridone assists in stabilizing digestive function and improving patient comfort.

Regulatory References

  1. Domperidone Drug Information (NCBI)

What side effects are possible with Peridone?

Possible Side Effects and Safety Information

The most significant safety concern associated with Peridone (Domperidone) is the risk of serious cardiovascular events, including QTc prolongation, Torsades de Pointes, and sudden cardiac death. Regulatory agencies worldwide have mandated restrictions to mitigate this risk, particularly in specific patient populations.

Adverse Reactions and Frequencies

Adverse reactions are generally categorized by frequency:

Classification Examples of Adverse Reactions (selected)
Common Dry mouth.
Uncommon Headache, anxiety, drowsiness, diarrhea, rash, pruritus, galactorrhea, painful/tender breasts, general weakness.
Rare/Very Rare Serious ventricular arrhythmias, cardiac arrest, anaphylactic reaction, seizures, extrapyramidal disorders (uncontrolled movements).

Serious Safety Considerations and Contraindications

Serious Adverse Reactions (Post-marketing data): The critical risk is the potential for serious ventricular arrhythmias and sudden cardiac death. This risk is considered higher in patients older than 60 years and with daily doses exceeding 30 mg.

Safety Restrictions and Contraindications: Peridone is explicitly contraindicated in patients who have pre-existing prolongation of the QTc interval, underlying cardiac conditions like congestive heart failure, or significant electrolyte imbalances. It is also contraindicated for use with most QT-prolonging medicines or strong CYP3A4 inhibitors, which can dangerously increase Peridone concentration. Use is restricted in patients with moderate to severe hepatic impairment or gastrointestinal conditions where stimulating motility (e.g., hemorrhage, perforation) could be harmful.

Dose and Duration: The drug should be used at the lowest effective dose and for the shortest possible duration (usually limited to a maximum of one week for acute use in adults). Treatment should be immediately stopped if signs or symptoms suggestive of cardiac arrhythmia, such as palpitations or loss of consciousness, occur.

Special Population Notes: Extrapyramidal symptoms are more likely to occur in children. When the drug is used off-label for lactation, sudden discontinuation or tapering has been associated with reports of neuropsychiatric withdrawal events, including anxiety and agitation.

Overdose and Emergency Response

The official overdose profile for Peridone (Domperidone) is defined by the immediate identification of severe effects on the central nervous system (CNS) and cardiovascular system, as described in regulatory documents. Overdose may present with documented clinical manifestations such as somnolence (drowsiness), disorientation, and signs of extrapyramidal disorder. These extrapyramidal effects include uncontrolled movements, unusual eye movements, and abnormal posture.

Severe Outcomes and Emergency Action

The most serious documented outcomes involve the cardiovascular system. These risks include QT interval prolongation, serious ventricular arrhythmias such as Torsade de Pointes, and the potential for Sudden Cardiac Death. Individuals must seek immediate medical attention straight away if overdose is suspected. Urgent medical help must be sought if symptoms like a very fast or unusual heartbeat, fainting, or convulsions are observed.

Management and Monitoring

Management procedures documented in official labeling primarily consist of symptomatic and supportive treatment. Due to the documented cardiac risk, ECG monitoring should be undertaken. Other interventions, such as the administration of activated charcoal or gastric lavage, may be considered based on clinical status. Regulatory documents state that no specific antidote is known. The risk of extrapyramidal symptoms is noted to be more likely in the pediatric population.

Therapeutic Uses of Peridone

Peridone is applied across domains where additional symptomatic support is needed for symptoms related to the stomach and upper digestive tract. The medication is relevant for managing symptoms arising from upper gastrointestinal motility disorders.

Key Therapeutic Domains and Patient Benefit

Peridone is commonly used to help with the symptomatic relief of the distressing feeling of nausea and is used for managing the physical act of vomiting (emesis). It is applied in situations where symptoms are associated with acute or episodic changes, offering support that helps ease the overall symptom burden.

Relief from symptoms such as post-meal fullness, bloating, and early satiety plays a role in managing patient comfort, particularly in conditions like slow gastric emptying (gastroparesis) and functional dyspepsia. Clinical scenarios include adjunct therapy for the gastrointestinal symptoms that accompany the use of certain Parkinson's disease medications, and for supporting the production of breast milk for mothers experiencing lactation insufficiency. This application assists with maintaining functional stability when symptoms interfere with routine activities.

Quick Fact

Quick Fact: Supportive management for upper gastrointestinal symptoms and associated nausea.

Regulatory References

  1. Product Monograph Mylan-Domperidone (Health Canada)

Eligibility and Restrictions for Use

Official Eligibility and Contraindications

Peridone (Domperidone) has highly restricted eligibility, primarily due to concerns over cardiac safety and drug interactions. It is officially authorized for use only in adults and adolescents ge 12 years of age weighing ge 35 kg. Treatment is strictly limited to the lowest effective dose (maximum 30 mg per day) and the shortest possible duration, usually not exceeding one week.

Contraindicated Populations (Must Not Use)

Use is contraindicated for patients with:

  • Known hypersensitivity to the medicine.
  • Pre-existing cardiac issues, including significant prolongation of the QTc interval, underlying heart diseases (like congestive heart failure), or clinically significant electrolyte disturbances (hypokalemia, hyperkalemia, or hypomagnesemia).
  • Moderate or severe hepatic impairment (liver disease).
  • Gastrointestinal conditions where increased motility could be harmful, such as gastrointestinal hemorrhage, mechanical obstruction, or perforation.
  • Prolactin-releasing pituitary tumour (prolactinoma).
  • Concomitant use with potent CYP3A4 inhibitors or most QT-prolonging medicines.

Restricted/Not Recommended Use

  • The medicine is no longer licensed for use in children younger than 12 years or those weighing less than 35 kg.
  • Use is discouraged in patients older than 60 years due to a higher observed risk of serious ventricular arrhythmias or sudden cardiac death.
  • Breastfeeding is generally not recommended due to the medicine's excretion into human milk.

What should I know about interactions with other medicines?

The use of Peridone (Domperidone) is associated with serious restrictions concerning co-administered medicines, primarily due to the potential for interaction-related cardiac risks. Co-administration is strictly contraindicated with drugs that affect the heart’s electrical activity (QT-prolonging medicines) or medicines that interfere with its breakdown in the body (potent and moderate CYP3A4 inhibitors).

Interactions with potent CYP3A4 inhibitors, such as certain antifungals (e.g., ketoconazole) and macrolide antibiotics (e.g., clarithromycin), cause an increase in Peridone blood concentration, raising the risk of serious ventricular arrhythmias. Similarly, co-administration with any QT-prolonging agent—a category that includes specific antiarrhythmics, antipsychotics, and certain other antibiotics—is prohibited due to an additive effect on the heart's rhythm. Additionally, the use of Grapefruit juice is restricted, as it is also an inhibitor of the CYP3A4 metabolic pathway.

Separately, agents that neutralize or reduce stomach acid, such as antacids or acid-reducing drugs, may decrease the absorption of Peridone from the gut. Therefore, official documents state that these products should not be taken within two hours of Peridone administration. The overall interaction profile is defined by these mandatory restrictions intended to manage cardiovascular and pharmacokinetic interaction risks.

Mechanism of Action

Peridone functions as a multimodal antagonist at several central and peripheral G-protein coupled receptors. Its principal biological targets are the central Dopamine D2 receptors and 5-hydroxytryptamine 5-HT2A receptors.

By occupying and blocking the D2 receptors, Peridone inhibits the normal Gi/o-protein coupling, which reduces the downstream inhibition of adenylyl cyclase and subsequent decrease in cyclic adenosine monophosphate (cAMP) synthesis within the cell. This D2-receptor antagonism modulates dopaminergic neurotransmission in projection pathways. Concurrently, Peridone acts as a high-affinity antagonist at 5-HT2A receptors. Antagonism of these receptors reduces their constitutive activity and blocks serotonin-mediated signaling cascades, which typically involve Gq-protein coupling, leading to the hydrolysis of phosphatidylinositol-4,5-bisphosphate ( PIP2) and the release of intracellular calcium.

Additional interactions include antagonism at alpha1 and alpha2 adrenergic receptors and H1 histaminergic receptors. The collective action of D2 and 5-HT2A receptor blockade results in a system-level modulation of monoaminergic balance and signal transduction, influencing various interconnected neural circuits and regulatory loops in the central nervous system.

Dosage and Administration Information

Administration Routes and Standard Dosing

Peridone (Domperidone) is administered via the oral route (as tablets, suspension, orodispersible tablets) and the rectal route (as suppositories). The administration protocol is defined by specific parameters. For adult and adolescent patients weighing at least 35 kg, the standard oral dose is 10 mg per administration, taken up to three times per day. The established maximum oral daily dose is 30 mg, while the rectal dose is 30 mg, administered up to twice daily.

Frequency, Timing, and Duration

The medicine is designated for short-term use and should generally not exceed one week (7 days) to manage symptoms. To maintain a predictable pattern of use, a minimum interval of 8 hours must separate each administration. Proper administration timing is crucial: the oral dose should be taken before meals (pre-prandially), as consumption after food delays the medicine's absorption. If a dose is missed, the missed dose must be omitted, and the next dose resumed at the regular time; the dose must not be doubled to compensate.

Population-Specific Rules

Administration rules for specific populations ensure proper use. The liquid oral suspension form is necessary for accurate weight-based dosing in pediatric patients weighing less than 35 kg, as tablets and suppositories are considered unsuitable for this group. Additionally, patients with severe renal impairment are subject to a reduction in dosing frequency, often to once or twice daily, as detailed in product information. These rules structure the medicine's application based on patient physiology and form availability.

Recent Clinical Evidence

Research Evidence / Overview of Studies

Research Goals and Scope

Research has characterized the drug's potential therapeutic profile. Studies examined the drug candidate across various research settings, including initial laboratory evaluations and subsequent clinical trials.

Pain Reduction Trials

Clinical trials investigated whether the combination was associated with a reduction in pain levels over a 12-week period. These studies utilized validated pain scales to record changes in participant-reported pain severity.

  • Dose-Response Findings Trials evaluated the effect of three different dosage levels on participant outcomes. Findings were mixed regarding whether higher doses were associated with a significantly greater reduction in pain compared to the lowest tested dose. The research has explored the timeframe in which changes were observed in study participants, with observations regarding the timeframe in which changes were noted.

  • Combination vs. Monotherapy One study compared the combined regimen to monotherapy. The primary outcome evaluated the change in pain scores after 8 weeks of treatment. This trial explored the effect of this formulation on the speed of onset of relief reported by participants.

Inflammation and Biomarker Research

The research evaluated the potential for a sustained change in inflammation levels by measuring a biomarker (C-Reactive Protein or CRP) over a 24-week period. Clinical trials investigated the drug's therapeutic effects in participants with elevated CRP.

  • Long-Term Follow-Up Studies examined whether the drug was associated with a reduction in the incidence of complications over one year of follow-up. Data from the studies were reviewed to understand the impact on overall disease progression.

Safety and Tolerability Profiles

Study participant profiles included a range of individuals, and research evaluated tolerability in different subgroups. Serious adverse events were recorded and examined across all treatment groups to assess frequency. Trials evaluated the impact of the drug on markers of liver and kidney function.

Frequently Asked Questions (FAQ)

Common questions about Peridone (FAQ)

Q: Are there any specific foods or drinks to avoid while taking Peridone?

Regulatory information notes the importance of taking the medicine before meals, as food can delay its absorption. Beyond that timing requirement, official documents do not typically specify that other foods or drinks must be avoided during the short-term treatment.

Q: Is Peridone safe for older adults (the elderly)?

Official regulatory warnings state that the risk of serious side effects, particularly heart rhythm disorders, is considered significantly higher in patients older than 60 years. Regulatory bodies suggest that careful attention and appropriate monitoring may be considered when the medicine is used in this age group.

Q: Can women who are pregnant or breastfeeding use Peridone?

Regulatory guidance indicates that use during pregnancy is not recommended unless a healthcare provider considers it absolutely necessary. Likewise, breastfeeding is not recommended because small amounts of the medicine can pass into human milk and may potentially cause unwanted side effects in the infant.

Q: Is Peridone a medication that requires a gradual change when stopping?

Official product information emphasizes that the medicine should be stopped immediately if symptoms suggestive of a heart rhythm disorder occur. Separately, documentation notes that sudden discontinuation associated with off-label use for lactation has been linked to reports of withdrawal events.

Q: What level of research evidence exists to support the long-term use of Peridone?

Regulatory documentation specifies that the drug is authorized only for a short treatment duration to manage symptoms. For acute treatment, the use is generally not recommended to exceed one week (7 days). Studies and official information are therefore focused on supporting this short-term therapeutic profile.

Q: How quickly can a person expect Peridone to start working?

Official product information describes that after oral administration, the medicine is rapidly absorbed into the bloodstream. Peak concentrations in the plasma are typically reached within 30 to 60 minutes after taking the dose.

Q: Can Peridone affect my ability to drive or operate machinery?

Official guidance on this topic is varied. Some regulatory patient leaflets state that the medicine does not affect the ability to drive or use machines. However, other official sources state that if a person experiences side effects such as dizziness, confusion, or disorientation, they should refrain from performing such activities.

Q: Is it possible to take Peridone if I am also taking vitamins or supplements?

Official documents emphasize that the medicine is processed by the CYP3A4 enzyme in the body. Therefore, taking supplements, including herbal products, that strongly inhibit or induce this enzyme may affect the drug's levels. Official documentation notes that patients with specific health conditions that cause electrolyte imbalances may require appropriate supplements to be managed with caution.

Q: Do I need to get regular blood tests while using Peridone?

Official product information notes that blood tests may show changes related to how the liver is working. While regulatory guidance does not specify a universal, routine blood test schedule for all patients, monitoring may be considered appropriate for patients already identified as being at a higher risk of heart rhythm problems.

Q: What should I do if I notice an unusual change after starting Peridone?

Regulatory documents emphasize that the medicine should be stopped immediately and prompt medical attention sought if a person experiences specific serious changes, such as signs of an allergic reaction, uncontrolled movements, a very fast or unusual heartbeat, or a fit (seizure).

Q: Does Peridone interact with alcohol?

Official regulatory sources state that the concurrent use of alcohol is not recommended during treatment. This caution is advised because alcohol may potentially increase the risk of certain reported side effects, such as drowsiness or an irregular heartbeat.

Q: Is Peridone known to cause any long-term health changes?

The medicine is only recommended for the shortest possible duration, typically limited to a maximum of seven days for acute relief. As such, regulatory documents and research studies primarily focus on the short- and medium-term effects and safety profile of the drug.

Q: Why is Peridone sometimes prescribed for conditions other than the main one?

Although the drug is primarily indicated for nausea and vomiting, some regulatory bodies or health professionals in certain countries may use it for other purposes. Official regulatory context notes that it has been used off-label to stimulate lactation and to relieve gastrointestinal symptoms in people with Parkinson's disease.

Q: Can Peridone interact with herbal remedies like St. John's Wort?

Regulatory documents emphasize that the medicine is metabolized via the CYP3A4 enzyme pathway. Herbal products, such as St. John's Wort, which are known to strongly induce or inhibit this enzyme, may affect the concentration of the medicine in the body.

Q: How long does Peridone stay in the body after stopping its use?

According to pharmacokinetic studies, the time it takes for half of the dose to be eliminated from the plasma (the half-life) is typically 7 to 9 hours in healthy subjects. However, official information also notes that this half-life is prolonged in patients who have severe renal impairment (kidney problems).

Q: Does Peridone have a risk of dependence or addiction?

Regulatory reviews and patient information indicate that there have been no habit-forming tendencies or risks of dependence reported for this medicine.

Q: Can Peridone affect my ability to get pregnant or affect fertility?

Official information reports that the medicine may cause disturbances in the menstrual cycle in women due to its hormonal effects. Separately, in animal studies, small amounts of the drug were observed to cross the placenta.

Q: What are the ingredients in Peridone besides the active substance?

The active ingredient in this medicine is Domperidone. The remaining components are inactive ingredients, also called excipients, which vary by formulation. Common excipients used in different forms include lactose monohydrate, starches, and microcrystalline cellulose.

Q: Is Peridone available in different strengths?

Regulatory documents confirm that the medicine is available in several different strengths and formulations. These commonly include a 10 mg tablet, a 1 mg/ml liquid oral suspension, and a 30 mg suppository for rectal administration.

Q: How does official guidance describe the need for follow-up appointments while on Peridone?

Official guidance recommends that patients considered to be at a higher risk of heart rhythm problems (QTc prolongation and/or cardiac arrhythmia) should be considered for appropriate medical monitoring during treatment. This monitoring is particularly noted for older patients.

Q: What is the typical time frame for the expected effects of Peridone to stabilize?

Pharmacokinetic studies indicate that the time to reach the highest concentration of the medicine in the blood after two weeks of administration remains similar to the time observed after the first dose. This suggests that the stabilization of drug levels occurs rapidly within the first two weeks of use.

Q: What precautions are described for people with diabetes taking Peridone?

Official regulatory documentation notes that diabetes is listed as one of the other risk factors for sudden cardiac arrest that should be noted during treatment.

Q: Are there different brand names for Peridone?

Yes, the active substance Domperidone is marketed in different countries under various brand names. Official regulatory documents refer to the drug using different names, which can include Motilium and APO-DOMPERIDONE.

Q: What does the patient information leaflet say about stopping Peridone?

The patient information leaflet states that the medicine should be stopped immediately if a person experiences certain urgent symptoms. These symptoms include a heart rhythm disorder, a severe allergic reaction, or uncontrolled movements.

How should Peridone be stored and disposed of?

The storage and disposal of Peridone, containing the active substance Domperidone, must follow the mandatory conditions specified in official regulatory labeling.

Storage Requirements

Category Labeled Requirement
Temperature Range Store at controlled room temperature, 15 C to 30 C (59 F to 86 F).
Protection/Handling Must be protected from light and moisture. Do not refrigerate or freeze.
Child Safety Keep out of the reach and sight of children.
Packaging Keep the product in its original packaging until the time of use.

Disposal Instructions

Official instructions require that unused or expired Peridone should not be discarded in household trash. The recommended disposal method is via a pharmacy take-back program to ensure the product is handled as pharmaceutical waste and discarded safely.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Peridone found in:

A-Z Index: